Seventure Partners
Edit

Seventure Partners

https://www.seventure.fr
Last activity: 08.02.2024
With over €660m in assets under management as of the end of 2016, Seventure Partners is a leading venture capital firm in Europe. Since 1997, Seventure Partners has invested in innovative businesses with high growth potential in Digital technologies, especially fintech & insurtech, in France and Germany, and in the Life sciences field across Europe, North America ans Asia. Investments can range between €500k and €10m per round, or up to €20m per company, from early to late stage. Seventure is a subsidiary of Natixis Global Asset Management. Natixis is the corporate investment management and financial services arm of Groupe BPCE, the second-largest French bank. For more details: www.seventure.com
Followers
9.92K
News
244
Portfolio
4
Mentions
61
Location: France, Ile-de-France, Paris
Employees: 11-50
Founded date: 1997
Investment Type: Venture Capital
Investment Stage: Series A; Series B; Series C; Series D; Series E; Series F; Series G; Series H

Portfolio 4

DateNameWebsiteTotal RaisedLocation
30.03.2023Glopalmerchants....$26.26MFrance, Il...
29.03.2023Glopalglopal.com$21.78MMetropolit...
05.05.2021Cytoki Pha...cytokiphar...$45MDenmark, G...
10.11.2014Humedics G...humedics.e...$7.83MGermany, B...

News 244

DateTitleDescription
05.12.2023Eligo Bioscience Raises $30 Million To Write a Novel Chapter...Eligo Bioscience, a pioneering gene-editing company focused on addressing diseases driven by the exp...
31.10.2023MaaT Pharma to Present Preclinical Data at SITC on MaaT034, ...MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotech company and a leader in the d...
30.10.2023Enterome Selected to The Leukemia & Lymphoma Society’s T...Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and li...
26.10.2023MaaT Pharma Announces Positive Outcome Following DSMB Review...MaaT Pharma today announced that the DSMB unanimously recommended that the open-label, single arm pi...
26.10.2023Pharma announces positive outcome following DSMB review rein...Maat Pharma announces that the DSMB unanimoulsy recommended that the open-label, single arm pivotal ...
09.10.2023CorWave announces the grand opening of its manufacturing fac...A French company that develops and manufactures innovative cardiac assist devices, held the grand op...
29.08.2023Citryll Announces Appointments of Eduardo Bravo as CEO and T...Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat immune-med...
24.08.2023Alliance Promotion Microbiote applauds the new legislation s...The Alliance Promotion Microbiote (APM), a prominent player dedicated to the development, production...
30.06.2023Enterome announces first patient dosed in a Phase 1/2 trial ...Enterome today announces that the first patient was dosed in the Phase 1/2 'AUDREY' trial evaluating...
14.06.2023Enterome’s new OncoMimics™ immunotherapy, EO2463, demonstrat...Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and li...
Show more

Mentions in press and media 61

DateTitleDescriptionSource
13.07.2023Rostock-based insurtech hepster raises €10 million to focus ...German embedded insurtech hepster has raised €10 million in a Series B funding round. Via its API it...tech.eu/20...
17.03.2023AI-Powered Eyesight Correction Proves the Most Convincing to...Unicorn CUP Finals determined the final winner of Unicorn Battles Q1 2023 11 winning startups from i...itkey.medi...
10.03.2023Winners of Unicorn Battles Q1 2023 Will Meet at the Unicorn ...After nine industry-specific Unicorn Battles Q1 2023, Unicorn CUP Finals will take place on March 16...itkey.medi...
03.01.2023Parisian customer data company mediarithmics raises €7 milli...Paris-based customer data platform mediarithmics has collected €7 million in its latest funding roun...tech.eu/20...
11.10.2022Clinical Microbiomics set to accelerate its expansion with E...Seventure Partners, a worldwide leading microbiome venture capital, and Clinical Microbiomics A/S, a...seventure....
03.05.2022Tubulis Closes €60 Million Series B Financing to Accelerate ...May 3, 2022htgf.de/en...
07.03.2022Tencent backs Cambridge-based startup in $67 million funding...Cambridge-based player in the field of microbiome-based therapeutics, biomarkers and targets, Microb...tech.eu/20...
05.05.2021Cytoki Pharma cierra una ronda de €38M liderada por Lundbeck...05/05/2021 Nota de prensa YSIOS CAPITAL INVIERTE EN CYTOKI PHARMA. − La compañía biotecnológica C...webcapital...
05.05.2021Cytoki Pharma secures $45M Series A round lead by Lundbeckfo...05/05/2021 Press release CYTOKI PHARMA RAISES $45 MILLION SERIES A FINANCING. Proceeds to support...webcapital...
30.04.2021Parisian automated spend management solution Expensya raises...Expensya, the Paris-based automated spend management solution for businesses has raised $20 million....tech.eu/br...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In